Quantcast

Latest Diabetic foot Stories

2011-03-08 08:00:00

SAN DIEGO, March 8, 2011 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced the publication of positive findings from the Company's Matrix Phase 2b clinical study. The clinical paper titled, "Formulated Collagen Gel Accelerates Healing Rate Immediately after Application in Patients with Diabetic Neuropathic Foot Ulcers," to be published in Wound Repair and Regeneration, an official journal of the Wound Healing Society, is now available online at...

2011-02-15 07:00:00

BRIDGEWATER, N.J. and TORONTO, Feb. 15, 2011 /PRNewswire/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Sunnybrook Health Sciences Centre (Toronto, Canada) announced that they have entered into a research agreement and licensing option for vasculotide, an investigational compound to treat chronic wounds. This includes neuropathic diabetic foot ulcers caused by a lack of sensation and neuropathic ulcers that are complicated by peripheral arterial disease, commonly called neuroischemic...

2011-02-05 00:00:42

A comprehensive Foot Care Program for RNs is offered online and requires no travel, no time away from home or work and no specific dates or hours of attendance. Foot care is a necessary skill for RNs caring for diabetics. Poor or no foot care can cause infections, amputations, even death in diabetics. Austin, TX (Vocus/PRWEB) February 04, 2011 Professional Education, LLC's Foot Care Program for RNs online enhances their knowledge-base in diabetic foot care. Diabetes Mellitus is diagnosed...

2011-02-03 06:30:00

LAS VEGAS, Feb. 3, 2011 /PRNewswire/ -- CardioVascular BioTherapeutics, Inc. (Pink Sheets: CVBT) today announced it has submitted an application to the U.S. FDA to obtain "fast track" designation for CVBT-141B, its biological therapy to treat ischemic diabetic wounds based on the active ingredient fibroblast growth factor-1 (FGF-1). The FDA grants "fast track" designation to accelerate the development of promising new therapies that treat a serious medical condition and for which there...

2010-11-10 12:32:00

CANTON, Mass., Nov. 10, 2010 /PRNewswire/ -- Organogenesis, Inc. announced today that Apligraf®, the only product with FDA approval for the treatment of both diabetic foot ulcers and venous leg ulcers, will have two new procedure codes assigned by the Centers for Medicare & Medicaid Services (CMS) as of January 2011. The new codes will enable physicians to receive appropriate reimbursement for each application of Apligraf in accordance with its FDA labeling criteria,...

2010-11-10 08:53:00

ADDISON, Texas, Nov. 10, 2010 /PRNewswire/ -- ULURU Inc. (NYSE Amex: ULU) today provided a clinical update and summary of recent participation at major wound care conferences. During the past 45 days Altrazeal® has been presented at three major wound care conferences Symposium of Advanced Wound Care ("SAWC") Clinical Symposium on Advances in Skin and Wound Care ("CSASWC") Diabetic Limb Salvage 2010 ("DLS") Participation in these conferences not only benefit our...

2010-10-25 13:34:00

In Conjunction with American Diabetes Month, November 2010 ROSEMONT, Ill., Oct. 25 /PRNewswire-USNewswire/ -- The statistics surrounding diabetes and diabetic related health issues are staggering. Diabetes is the cause of approximately 60,000 lower extremity amputations performed annually in the US. According to the American Orthopaedic Foot & Ankle Society (AOFAS) many of these amputations are preventable with ongoing, thorough, and proper foot care. To help increase awareness...

2010-09-30 07:00:00

ADDISON, Texas, Sept. 30 /PRNewswire/ -- ULURU Inc. (NYSE Amex: ULU) announced today that the Company will have an extensive presence at the Clinical Symposium on Advances in Skin and Wound Care "CSAWC" which will be held on September 30 - October 3, 2010 in Orlando, Florida. The primary objectives of CSAWC are the education and advancement of clinical practice for wound care professionals. In addition to having a booth presence at the exhibit, ULURU and Altrazeal® will...

2010-09-28 11:15:00

CANTON, Mass., Sept. 28 /PRNewswire/ -- Organogenesis, Inc. announced that its Apligraf® bilayered living cellular construct has been approved for the treatment of diabetic foot ulcers and other chronic wounds by the Saudi Food and Drug Authority (SFDA) of the Kingdom of Saudi Arabia. Apligraf is a living cell based product used by physicians to heal chronic wounds in patients in the U.S. and around the world. "With diabetes being a widespread and growing medical problem...

2010-08-18 07:30:00

FORT WORTH, Texas, Aug. 18 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) announced today that its new international distributor, Spiramed (Pty) Ltd, exhibited its advanced wound care collagen product, CellerateRX® last weekend at the DFWG (Diabetic Foot Working Group) congress in Cape Town and has already planned exhibitions at two additional upcoming conferences. This second meeting of the DFWG congress was attended by over 120...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related